01.20.17
Cytovance Biologics, a biopharmaceutical contract manufacturer of mammalian and microbial biologics, has appointed Mike O'Mara as senior vice president of manufacturing operations.
"As Cytovance continues to grow, an efficient and collaborative manufacturing operation becomes critical to our clients' success," said Darren Head, chief executive officer, Cytovance. "Mike brings to his new role a strong track record of success leading teams across our business, including mammalian, microbial operations and cell therapy manufacturing. He is the right leader to help shape our vision as we continue to grow and will be a great addition to our senior leadership team."
Mr. O'Mara has more than 23 years experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell therapy manufacturing processes ranging from Preclinical/Phase I through Commercial. Prior to Cytovance, he worked at DynPort Vaccine Corporation as senior director of manufacturing for 2 years.
"As Cytovance continues to grow, an efficient and collaborative manufacturing operation becomes critical to our clients' success," said Darren Head, chief executive officer, Cytovance. "Mike brings to his new role a strong track record of success leading teams across our business, including mammalian, microbial operations and cell therapy manufacturing. He is the right leader to help shape our vision as we continue to grow and will be a great addition to our senior leadership team."
Mr. O'Mara has more than 23 years experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell therapy manufacturing processes ranging from Preclinical/Phase I through Commercial. Prior to Cytovance, he worked at DynPort Vaccine Corporation as senior director of manufacturing for 2 years.